Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
70,604,563
-
Share change
-
+1,496,946
-
Total reported value
-
$1,914,663,149
-
Put/Call ratio
-
96%
-
Price per share
-
$27.13
-
Number of holders
-
197
-
Value change
-
+$15,874,395
-
Number of buys
-
99
-
Number of sells
-
90
Institutional Holders of PORTOLA PHARMACEUTICALS INC - COM (PTLA) as of Q2 2019
As of 30 Jun 2019,
PORTOLA PHARMACEUTICALS INC - COM (PTLA) was held by
197 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
70,604,563 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., Temasek Holdings (Private) Ltd, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, CADIAN CAPITAL MANAGEMENT, LP, STATE STREET CORP, Jackson Square Partners, LLC, FRED ALGER MANAGEMENT INC, and HIGHLAND CAPITAL MANAGEMENT LP.
This page lists
197
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.